Total Payments
$833,607
2024 Payments
$104,052
Companies
43
Transactions
1,591
Medicare Patients
965
Medicare Billing
$85,059

Payment Breakdown by Category

Other$617,581 (74.1%)
Travel$103,130 (12.4%)
Consulting$83,026 (10.0%)
Food & Beverage$28,588 (3.4%)
Research$1,200 (0.1%)
Education$81.73 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $617,581 245 74.1%
Travel and Lodging $103,130 376 12.4%
Consulting Fee $83,026 45 10.0%
Food and Beverage $28,588 922 3.4%
Unspecified $1,200 1 0.1%
Education $81.73 2 0.0%

Payments by Type

General
$832,407
1,590 transactions
Research
$1,200
1 transactions

Top Paying Companies

Company Total Records Latest Year
GENZYME CORPORATION $377,291 424 $0 (2024)
Regeneron Healthcare Solutions, Inc. $351,442 561 $0 (2024)
ABBVIE INC. $38,568 136 $0 (2024)
PFIZER INC. $23,736 107 $0 (2024)
Dermavant Sciences, Inc. $11,759 20 $0 (2024)
Arcutis Biotherapeutics, Inc. $9,896 19 $0 (2024)
Lilly USA, LLC $8,373 58 $0 (2024)
Novartis Pharmaceuticals Corporation $6,562 25 $0 (2024)
UCB, Inc. $1,537 15 $0 (2024)
Ortho Dermatologics, a division of Bausch Health US, LLC $501.79 35 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $104,052 193 GENZYME CORPORATION ($65,901)
2023 $79,057 172 GENZYME CORPORATION ($56,637)
2022 $121,043 241 GENZYME CORPORATION ($51,778)
2021 $50,891 136 GENZYME CORPORATION ($23,908)
2020 $44,873 112 Regeneron Healthcare Solutions, Inc. ($21,121)
2019 $208,696 300 Regeneron Healthcare Solutions, Inc. ($123,171)
2018 $168,063 286 Regeneron Healthcare Solutions, Inc. ($89,729)
2017 $56,932 151 Regeneron Healthcare Solutions, Inc. ($29,809)

All Payment Transactions

1,591 individual payment records from CMS Open Payments — Page 1 of 64

Date Company Product Nature Form Amount Type
12/20/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Consulting Fee Cash or cash equivalent $2,128.00 General
Category: INFLAMMATION AND IMMUNOLOGY
12/19/2024 GENZYME CORPORATION Food and Beverage In-kind items and services $13.03 General
12/18/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $32.01 General
Category: Immunology
12/13/2024 Arcutis Biotherapeutics, Inc. Zoryve (Drug) Consulting Fee Cash or cash equivalent $2,475.00 General
Category: Dermatology
12/10/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $18.37 General
Category: IMMUNOLOGY
12/10/2024 Arcutis Biotherapeutics, Inc. Zoryve (Drug) Food and Beverage In-kind items and services $7.75 General
Category: Dermatology
12/06/2024 Lilly USA, LLC TALTZ (Drug), EBGLYSS Food and Beverage In-kind items and services $12.19 General
Category: Immunology
12/05/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $28.33 General
Category: Immunology
12/03/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $37.77 General
Category: Immunology
11/21/2024 GENZYME CORPORATION DUPIXENT (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,458.00 General
Category: Immunology
11/21/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $147.48 General
Category: Immunology
11/21/2024 GENZYME CORPORATION DUPIXENT (Biological) Travel and Lodging Cash or cash equivalent $46.00 General
Category: Immunology
11/21/2024 GENZYME CORPORATION DUPIXENT (Biological) Travel and Lodging Cash or cash equivalent $32.83 General
Category: Immunology
11/21/2024 Lilly USA, LLC TALTZ (Drug), EBGLYSS Food and Beverage In-kind items and services $27.51 General
Category: Immunology
11/21/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $11.88 General
Category: IMMUNOLOGY
11/16/2024 Dermavant Sciences, Inc. TAPINAROF (Drug) Consulting Fee Cash or cash equivalent $4,510.00 General
Category: DERMATOLOGY
11/16/2024 Dermavant Sciences, Inc. TAPINAROF (Drug) Travel and Lodging In-kind items and services $450.95 General
Category: DERMATOLOGY
11/16/2024 Dermavant Sciences, Inc. TAPINAROF (Drug) Travel and Lodging In-kind items and services $282.56 General
Category: DERMATOLOGY
11/16/2024 Dermavant Sciences, Inc. TAPINAROF (Drug) Travel and Lodging In-kind items and services $220.54 General
Category: DERMATOLOGY
11/16/2024 Dermavant Sciences, Inc. TAPINAROF (Drug) Food and Beverage In-kind items and services $134.71 General
Category: DERMATOLOGY
11/16/2024 Dermavant Sciences, Inc. TAPINAROF (Drug) Food and Beverage In-kind items and services $73.62 General
Category: DERMATOLOGY
11/16/2024 Dermavant Sciences, Inc. TAPINAROF (Drug) Travel and Lodging Cash or cash equivalent $64.00 General
Category: DERMATOLOGY
11/16/2024 Dermavant Sciences, Inc. TAPINAROF (Drug) Food and Beverage In-kind items and services $46.86 General
Category: DERMATOLOGY
11/16/2024 Dermavant Sciences, Inc. TAPINAROF (Drug) Food and Beverage In-kind items and services $41.76 General
Category: DERMATOLOGY
11/16/2024 Dermavant Sciences, Inc. TAPINAROF (Drug) Food and Beverage In-kind items and services $34.56 General
Category: DERMATOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 278 391 $46,448 $25,337
2022 8 223 342 $36,217 $21,795
2021 8 205 309 $31,471 $20,428
2020 9 259 380 $33,074 $17,500
Total Patients
965
Total Services
1,422
Medicare Billing
$85,059
Procedure Codes
33

All Medicare Procedures & Services

33 procedure records from CMS Medicare Utilization — Page 2 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 26 32 $4,736 $2,397 50.6%
17110 Destruction of up to 14 skin growths Office 2020 19 22 $3,366 $2,109 62.7%
17000 Destruction of skin growth Office 2020 44 52 $5,772 $2,049 35.5%
99203 New patient office or other outpatient visit, typically 30 minutes Office 2020 29 29 $4,263 $2,034 47.7%
11102 Tangential biopsy of single skin lesion Office 2020 26 29 $2,610 $1,693 64.9%
99202 New patient office or other outpatient visit, typically 20 minutes Office 2020 13 13 $1,313 $750.79 57.2%
99212 Established patient office or other outpatient visit, typically 10 minutes Office 2020 12 18 $1,062 $665.29 62.6%
17003 Destruction of 2-14 skin growths Office 2020 30 94 $1,034 $491.41 47.5%

About Kathryn Sowerwine

Kathryn Sowerwine is a Student in an Organized Health Care Education/Training Program healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2008. The National Provider Identifier (NPI) number assigned to this provider is 1477712867.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kathryn Sowerwine has received a total of $833,607 in payments from pharmaceutical and medical device companies, with $104,052 received in 2024. These payments were reported across 1,591 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($617,581).

As a Medicare-enrolled provider, Sowerwine has provided services to 965 Medicare beneficiaries, totaling 1,422 services with total Medicare billing of $85,059. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.

Practice Information

Products in Payments

  • DUPIXENT (Biological) $420,586
  • DUPIXENT (Drug) $143,058
  • DUPIXENT DUPILUMAB INJECTION (Biological) $119,538
  • RINVOQ (Biological) $29,515
  • ATOPIC DERMATITIS - DISEASE (Drug) $25,220
  • EUCRISA (Drug) $20,681
  • TAPINAROF (Drug) $9,960
  • Zoryve (Drug) $4,585
  • RINVOQ (Drug) $2,800
  • CIBINQO (Drug) $1,864
  • VTAMA (Drug) $1,799
  • HUMIRA (Biological) $1,477
  • SKYRIZI (Biological) $950.83
  • TALTZ (Drug) $876.28
  • Humira (Biological) $418.80
  • Sotyktu (Drug) $417.72
  • COSENTYX (Biological) $251.35
  • OPZELURA (Drug) $243.77
  • Bimzelx (Biological) $240.44
  • ARAZLO (Drug) $236.18

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Washington